|
RFC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.566100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.273620E-01 |
| Normal-vs-Stage2 |
9.565700E-02 |
| Normal-vs-Stage3 |
1.861480E-03 |
| Normal-vs-Stage4 |
2.917600E-01 |
| Stage1-vs-Stage2 |
4.382600E-01 |
| Stage1-vs-Stage3 |
3.456700E-03 |
| Stage1-vs-Stage4 |
9.142600E-01 |
| Stage2-vs-Stage3 |
2.346200E-01 |
| Stage2-vs-Stage4 |
7.307200E-01 |
| Stage3-vs-Stage4 |
2.068800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.688200E-02 |
| Normal-vs-AfricanAmerican |
7.389800E-02 |
| Normal-vs-Asian |
9.048600E-01 |
| Caucasian-vs-AfricanAmerican |
9.312200E-01 |
| Caucasian-vs-Asian |
3.536800E-01 |
| AfricanAmerican-vs-Asian |
2.851800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.120000E-02 |
| Normal-vs-Female |
5.097700E-02 |
| Male-vs-Female |
8.862800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.701600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.963560E-01 |
| Normal-vs-Age(61-80Yrs) |
1.249620E-02 |
| Normal-vs-Age(81-100Yrs) |
4.102300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.128000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.240400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.288610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.167850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.940200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.899010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.748200E-01 |
| Normal-vs-Grade 2 |
2.434000E-01 |
| Normal-vs-Grade 3 |
2.175300E-03 |
| Normal-vs-Grade 4 |
1.867360E-01 |
| Grade 1-vs-Grade 2 |
3.702000E-01 |
| Grade 1-vs-Grade 3 |
2.212000E-02 |
| Grade 1-vs-Grade 4 |
1.928000E-01 |
| Grade 2-vs-Grade 3 |
5.951200E-04 |
| Grade 2-vs-Grade 4 |
4.715200E-01 |
| Grade 3-vs-Grade 4 |
5.546600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.409800E-01 |
| Normal-vs-ccB subtype |
1.231620E-02 |
| ccA subtype-vs-ccB subtype |
3.818000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.248300E-02 |
| Normal-vs-N1 |
4.121800E-01 |
| N0-vs-N1 |
9.307800E-01 |
|
|
